MIRA INFORM REPORT

 

 

Report Date :

10.10.2008

 

IDENTIFICATION DETAILS

 

Name :

ABDI IBRAHIM ILAC SANAYI VE TICARET A.S.

 

 

Registered Office :

Eski Buyukdere Cad. Ayazaga Yolu No:5 Maslak Istanbul

 

 

Country :

Turkey

 

 

Financials (as on) :

31.12.2007

 

 

Date of Incorporation :

20.12.1974

 

 

Com. Reg. No.:

130296

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacture and trade of medicine

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

EUR 90 million

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

COMPANY IDENTIFICATION

 

NAME

:

ABDI IBRAHIM ILAC SANAYI VE TICARET A.S.

ADDRESS

:

Head Office : Eski Buyukdere Cad. Ayazaga Yolu No:5 Maslak Istanbul/ Turkey

Factory: Hadimkoy Yolu Hosdere Mevkii Tunc Cad. No:3 Buyukcekmece- Istanbul / Turkey

PHONE NUMBER

:

90-212-366 84 00

FAX NUMBER

:

90-212-286 91 77

 

 

LEGAL STATUS AND HISTORY

 

TAX OFFICE / NO

:

Buyuk Mukellefler / 0010052149

 

REGISTRATION NUMBER

:

130296

 

REGISTERED OFFICE

:

Istanbul Chamber of Industry

Istanbul Chamber of Commerce

 

DATE ESTABLISHED

:

20.12.1974

 

LEGAL FORM

:

Joint Stock Company

 

TYPE OF COMPANY

:

Private

 

REGISTERED CAPITAL

:

YTL 105,000,000

 

PAID-IN CAPITAL

:

YTL 105,000,000

 

HISTORY

:

 

 

 

 

Previous Registered Capital

: YTL 1.5 million

 

 

Regist. Capital Changed on

: 04.12.2002 (Commercial Registry Gazette Date/No: 12.12.2002 / 5695)

 

 

Previous Registered Capital

:YTL 84 million

 

 

Regist. Capital Changed on

:10.07.2006 (Commercial Registry Gazette Date/No: 13.07.2006 / 6598)

 

 

Previous Address

: Kore Sehitleri Caddesi No : 19 Zincirlikuyu- Istanbul

 

 

Address Changed On

: 10.09.2007 (Commercial Registry Gazette Date/No: 13.09.2007 / 6894)

 

 

OWNERSHIP / MANAGEMENT

 

SHAREHOLDERS

:

Abdi Ibrahim Holding A.S.

Nezih Barut

Nesrin Esirtgen

Bell Holding A.S.

Perfektup Ambalaj San.Ve Tic.A.S.  

Ahmet Cenan Esirtgen

 

49,9996 %

24,5 %

24,5 %

 

GROUP PARENT COMPANY

:

Abdi Ibrahim Holding A.S.

 

 

SISTER COMPANIES

:

Abdi Ibrahim Holding A.S.

Abdi Ibrahim Ilac Pazarlama A.S.

Aktivita Saglik Hizmetleri Sanayi ve Ticaret A.S.

Barut Ilac San Ve Tic. A.S.

Mecofarm Ilac ve Kozmetik Tanitim Hizmetleri Ticaret A.S.

Mecom Saglik Urunleri San. ve Tic

Tripharma Ilac San. ve Tic.A.S.

 

SUBSIDIARIES

 

:

Abdi Ibrahim Ilac Pazarlama A.S. (50 %)

Abdi Ibrahim sp.zo.o (Poland-Warsaw) (20 %)

Aktivita Saglik Hizmetleri Sanayi ve Ticaret A.S. (5 %)

Barut Ilac San ve Tic. A.S. (5 %)

Mecofarm Ilac ve Kozmetik Tanitim Hizmetleri Ticaret A.S. (20 %)

 

BOARD OF DIRECTORS

:

Nezih Barut

Nesrin Esirtgen

Ahmet Kamil Esirtgen

Erman Atasoy

Chairman

Vice Chairman

Member

Member

 

GENERAL MANAGER

:

Erman Atasoy

 

 

OPERATIONS

 

BUSINESS ACTIVITIES

:

Manufacture and trade of medicine

 

 

SECTOR

 

:

Chemicals

 

 

NUMBER OF EMPLOYEES

:

1,113

 

 

NET SALES

:

(YTL)

    7,429,443

  14,896,572

  32,146,151

  55,880,736

  89,735,890

150,952,892

245,053,936

360,461,836

361,436,309

424,215,258

477,197,464

507,652,466

42,491,763

 

 

(1996)

(1997)

(1998)

(1999)

(2000)

(2001)

(2002)

(2003)

(2004)

(2005)

(2006)

(2007)

(01.01-31.03.2008)

 

 

CAPACITY

:

(Boxes/Yr)

42,112,000

42,112,000

42,112,000

(Bottles/Yr)

57,456,000

57,456,000

57,456,000

(Tubes/Yr)

18,144,000

18,144,000

18,144,000

 

 

(2006)

(2007)

(2008)

 

 

IMPORT VALUE

:

USD 59,694,842

USD 89,600,894

USD 92,070,975

USD 142,646,712

USD 133,158,480

USD 208,651,367

USD 191,190,107

YTL 22,300,000

(2001)

(2002)

(2003)

(2004)

(2005)

(2006)

(2007)

(01.01-31.03.2008)

 

 

IMPORT COUNTRIES

:

Switzerland, France, UK, Germany, Ireland...

 

 

MERCHANDISE IMPORTED

 

:

Medicine and raw materials of medicine

 

 

EXPORT VALUE

:

USD 125,499

USD 240,934

USD 556,389

YTL 667,689

YTL 540,637

YTL 4,647,292

YTL 7,015,320

YTL 11,406,659

YTL 17,198,013

YTL 21,479,103

YTL 17,107,424

YTL 23,538,042

YTL 2,842,665

(1996)

(1997)

(1998)

(1999)

(2000)

(2001)

(2002)

(2003)

(2004)

(2005)

(2006)

(2007)

(01.01-31.03.2008)

 

EXPORT COUNTRIES

 

:

Northern Cyprus Turkish Republic, Libya, Algeria, Serbia, Uzbekistan, Kazakhstan, Russia, Ukraine, Switzerland, Denmark, Indonesia, Afghanistan, Yemen, Panama, Belize, Czech Republic, Netherlands…

 

 

MERCHANDISE EXPORTED

 

:

Medicine

 

 

PREMISES

:

Head Office: Eski Buyukdere Cad. Ayazaga Yolu No:5 Maslak Istanbul (owned)

 

Factory: Hadimkoy Yolu Hosdere Mevkii Tunc Cad. No:3 Buyukcekmece Istanbul (18,000 sqm closed area over a land of 40,000 sqm) (owned)

 

Branch & Warehouse: Omerli Koyu Maltepe Mevkii Hadimkoy - Istanbul. (rented)

 

 

FIXED CAPITAL INVESTMENTS

:

Investments are going on

 

 

TREND OF BUSINESS

:

Trend of business was steady in 2005, 2006 and 2007. There appears a considerable decline at sales volume in the first 3 months of 2008, but this is due to the structure of medicine sector. The sales of the firm does not realize orderly.

SIZE OF BUSINESS

:

Giant

 


 

FINANCE

 

MAIN DEALING BANKERS

:

Akbank Istanbul Kurumsal  branch in Istanbul

Turkiye Is Bankasi Maslak branch in Istanbul

HSBC Bank Merkez branch in Istanbul

Turk Ekonomi Bankasi Gayrettepe branch in Istanbul

Yapi ve Kredi Bankasi Levent branch in Istanbul

 

CREDIT FACILITIES

:

The subject company is making use of credit facilities.

 

PAYMENT BEHAVIOUR

:

No payment delays have come to our knowledge.

 

 

COMMENT ON FINANCIAL POSITION

 

FINANCIAL STRUCTURE (SUFFICENCY OF OWN RESOURCES)

 

High

 

As of 31.12.2007

LIQUIDITY

 

High

 

As of 31.12.2007

PROFITABILITY

 

Profitability was high in 2007.

 

There was a considerable decline at sales volume in the first 3 months of 2008. So the firm had heavy operating loss and net loss in the first quarter of 2008. However the sales volume of the first 3 months does not reflect the trend of business as the sales of the firm does not realize orderly. (For example the firm had YTL 51,367,449 net sales and YTL 7,568,535 loss between 1.1.-31.3.2007. However at the end of the year the sales reached up to YTL 507,652,466 and it had net profit of YTL 76,373,326 in 2007)

 

GAP BETWEEN COLLECTION-PAYMENT

PERIODS

 

Unfavorable

 

In 2006

GENERAL FINANCIAL

POSITION

 

The capitalization, liquidity and the profitability was high in 2007. There was a considerable decline at sales volume in the first 3 months of 2008. So the firm had heavy operating loss and net loss in the first quarter of 2008. However the sales volume of the first 3 months does not reflect the trend of business as the sales of the firm does not realize orderly.

 

 


 

CREDIT OPINION

 

CREDIT OPINION WITHOUT OBLIGATION

 

:

We are of the opinion that, a max. credit of EUR 90 million may be granted to the subject company.

 

 

 

 

Incr. in producers’ price index

 

Average YTL/$

Average YTL/EUR

Average YTL/GBP

(1998)

54.30 %

0.2657

0.2967

0.4410

(1999)

62.90 %

0.4278

0.4518

0.6843

(2000)

32.70 %

0.6251

0.5774

0.9480

(2001)

88.60 %

1.1991

1.0714

1.7300

(2002)

30.80 %

1.5168

1.3741

2.2001

(2003)

13.90 %

1.5302

1.7141

2.4982

(2004)

13.84 %

1.4266

1.7666

2.6001

(2005)

2.66 %

1.3499

1.6882

2.4623

(2006)

11.58 %

1.4309

1.7987

2.6377

(2007)

5.94 %

1.3075

1.7901

2.6133

(1.1.-31.03.2008)

6.26 %

1.2033

1.8179

2.3972

(1.1.-30.09.2008)

11.48 %

1.2146

1.8490

2.3755

 


 

BALANCE SHEETS

 

 

 

YTL

 

 

YTL

 

 

YTL

 

 

 

 

31.12.05

 

 

31.12.06

 

 

31.12.07

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

317.978.078

0.79

 

275.423.311

0.73

 

356.358.880

0.73

 

 

 Cash and Banks

48.566.782

0.12

 

19.251

0.00

 

89.162.173

0.18

 

 

 Marketable Securities

0

0.00

 

0

0.00

 

0

0.00

 

 

 Account Receivable

218.806.165

0.54

 

206.079.383

0.54

 

212.717.621

0.44

 

 

 Other Receivable

1.704.620

0.00

 

8.031.790

0.02

 

6.136.287

0.01

 

 

 Inventories

31.716.015

0.08

 

46.619.401

0.12

 

36.568.770

0.08

 

 

 Advances Given

1.144.329

0.00

 

133.612

0.00

 

775.888

0.00

 

 

 Other Current Assets

16.040.167

0.04

 

14.539.874

0.04

 

10.998.141

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

NON-CURRENT ASSETS

86.041.774

0.21

 

103.451.263

0.27

 

129.521.836

0.27

 

 

 Long-term Receivable

15.324

0.00

 

50.011

0.00

 

39.548

0.00

 

 

 Financial Assets

362.931

0.00

 

389.920

0.00

 

809.872

0.00

 

 

 Tangible Fixed Assets (net)

80.763.728

0.20

 

94.514.509

0.25

 

119.298.805

0.25

 

 

 Intangible Assets

4.629.023

0.01

 

8.181.492

0.02

 

9.047.660

0.02

 

 

 Other Non-Current Assets

270.768

0.00

 

315.331

0.00

 

325.951

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

404.019.852

1.00

 

378.874.574

1.00

 

485.880.716

1.00

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

139.851.511

0.35

 

87.360.544

0.23

 

115.812.348

0.24

 

 

 Financial Loans

72.444.446

0.18

 

38.271.030

0.10

 

81.195.193

0.17

 

 

 Accounts Payable

51.509.171

0.13

 

35.894.335

0.09

 

15.849.323

0.03

 

 

 Loans from Shareholders

0

0.00

 

0

0.00

 

0

0.00

 

 

 Other Short-term Payable

4.358.223

0.01

 

2.687.970

0.01

 

3.840.114

0.01

 

 

 Advances from Customers

1.961.292

0.00

 

0

0.00

 

0

0.00

 

 

 Taxes Payable

9.591.614

0.02

 

9.379.525

0.02

 

13.935.172

0.03

 

 

 Provisions

-1.219.329

0.00

 

-132.880

0.00

 

-292.439

0.00

 

 

 Other Current Liabilities

1.206.094

0.00

 

1.260.564

0.00

 

1.284.985

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

LONG-TERM LIABILITIES

7.572.638

0.02

 

8.566.364

0.02

 

10.747.376

0.02

 

 

 Financial Loans

0

0.00

 

0

0.00

 

0

0.00

 

 

 Securities Issued

0

0.00

 

0

0.00

 

0

0.00

 

 

 Long-term Payable

0

0.00

 

0

0.00

 

0

0.00

 

 

 Loans from Shareholders

0

0.00

 

0

0.00

 

0

0.00

 

 

 Other Long-term Liabilities

0

0.00

 

0

0.00

 

0

0.00

 

 

 Provisions

7.572.638

0.02

 

8.566.364

0.02

 

10.747.376

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

256.595.703

0.64

 

282.947.666

0.75

 

359.320.992

0.74

 

 

 Paid-in Capital

84.000.000

0.21

 

105.000.000

0.28

 

105.000.000

0.22

 

 

 Inflation Adjustment of Capital

42.194.700

0.10

 

0

0.00

 

0

0.00

 

 

 Reserves

103.920.707

0.26

 

147.238.914

0.39

 

177.947.666

0.37

 

 

 Revaluation Fund

10.481

0.00

 

0

0.00

 

0

0.00

 

 

 Accumulated Losses(-)

-21.542.739

-0.05

 

0

0.00

 

0

0.00

 

 

 Net Profit (loss)

48.012.554

0.12

 

30.708.752

0.08

 

76.373.326

0.16

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND EQ.

404.019.852

1.00

 

378.874.574

1.00

 

485.880.716

1.00

 

 

 

INCOME STATEMENTS

 

 

 

 

 

YTL

 

 

YTL

 

 

YTL

 

 

 

 

2005

 

 

2006

 

 

2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales

424.215.258

1.00

 

477.197.464

1.00

 

507.652.466

1.00

 

 

 Cost of Goods Sold

200.344.512

0.47

 

215.169.166

0.45

 

222.882.666

0.44

 

 

Gross Profit

223.870.746

0.53

 

262.028.298

0.55

 

284.769.800

0.56

 

 

 Operating Expenses

164.526.329

0.39

 

211.821.096

0.44

 

172.794.925

0.34

 

 

Operating Profit

59.344.417

0.14

 

50.207.202

0.11

 

111.974.875

0.22

 

 

 Other Income

11.395.022

0.03

 

15.131.627

0.03

 

10.538.794

0.02

 

 

 Other Expenses

10.379.833

0.02

 

19.344.448

0.04

 

24.575.927

0.05

 

 

 Financial Income-Expenses(net)

4.267.835

0.01

 

-7.063.314

-0.01

 

-2.293.347

0.00

 

 

Profit (loss) Before Tax

64.627.441

0.15

 

38.931.067

0.08

 

95.644.395

0.19

 

 

 Tax Payable

16.614.887

0.04

 

8.222.315

0.02

 

19.271.069

0.04

 

 

Net Profit (loss)

48.012.554

0.11

 

30.708.752

0.06

 

76.373.326

0.15

 

 

 

FINANCIAL RATIOS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2005

 

 

2006

 

 

2007

 

 

 

LIQUIDITY RATIOS

 

 

 

 

 

 

 

 

 

 

Current Ratio

2.27

 

 

3.15

 

 

3.08

 

 

 

Acid-Test Ratio

1.92

 

 

2.45

 

 

2.66

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSET STRUCTURE RATIOS

 

 

 

 

 

 

 

 

 

 

Inventory/Total Assets

0.08

 

 

0.12

 

 

0.08

 

 

 

Short-term Receivable/Total Assets

0.55

 

 

0.57

 

 

0.45

 

 

 

Tangible Assets/Total Assets

0.20

 

 

0.25

 

 

0.25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TURNOVER RATIOS

 

 

 

 

 

 

 

 

 

 

Inventory Turnover

6.32

 

 

4.62

 

 

6.09

 

 

 

Stockholders' Equity Turnover

1.65

 

 

1.69

 

 

1.41

 

 

 

Asset Turnover

1.05

 

 

1.26

 

 

1.04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL STRUCTURE

 

 

 

 

 

 

 

 

 

 

Stockholders' Equity/Total Assets

0.64

 

 

0.75

 

 

0.74

 

 

 

Current Liabilities/Total Assets

0.35

 

 

0.23

 

 

0.24

 

 

 

Financial Leverage

0.36

 

 

0.25

 

 

0.26

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PROFITABILITY RATIOS

 

 

 

 

 

 

 

 

 

 

Net Profit/Stockholders' Eq.

0.19

 

 

0.11

 

 

0.21

 

 

 

Operating Profit Margin

0.14

 

 

0.11

 

 

0.22

 

 

 

Net Profit Margin

0.11

 

 

0.06

 

 

0.15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COLLECTION-PAYMENT

 

 

 

 

 

 

 

 

 

 

Average Collection Period (days)

185.70

 

 

155.50

 

 

150.88

 

 

 

Average Payable Period (days)

92.56

 

 

60.05

 

 

25.60

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME STATEMENT

 

 

 

YTL

 

 

 

 

 

1.1-31.03.2008

 

 

 

 

 

 

 

 

 

 

Net Sales

42.491.763

 

1.00

 

 

 Cost of Goods Sold

27.255.554

 

0.64

 

 

Gross Profit

15.236.209

 

0.36

 

 

 Operating Expenses

33.728.625

 

0.79

 

 

Operating Profit

-18.492.416

 

-0.44

 

 

 Other Income

5.841.124

 

0.14

 

 

 Other Expenses

2.406.407

 

0.06

 

 

 Financial Expenses

988.186

 

0.02

 

 

Profit (loss) Before Tax

-16.045.885

 

-0.38

 

 

 Tax Payable

0

 

0.00

 

 

Net Profit (loss)

-16.045.885

 

-0.38

 

 

 

 

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.48.72

UK Pound

1

Rs.82.17

Euro

1

Rs.65.90

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions